by Sam Eskandari | Oct 26, 2016 | News
October 26, 2016, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), an emerging discovery and IP development company, is pleased to announce that CanniMed Ltd. of Saskatoon, Canada, is the new supplier of cannabis strains for Cannevert...
by Lui Franciosi | Oct 20, 2016 | News
VANCOUVER, October 20, 2016, — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), (“Veritas” or the “Company”), an emerging discovery and IP development company, announced that on August 23, 2016. Cannevert Therapeutics Ltd., (“CTL”) had been awarded a...
by Lui Franciosi | Oct 11, 2016 | News
October 11, 2016, Vancouver, B.C. – Veritas Pharma Inc. (“VRT” or the “Company”) (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) is pleased to announce that Veritas has completed advancing $750,000 to Cannevert Therapeutics Ltd. With this payment the Company has made 50%...
by Lui Franciosi | Oct 4, 2016 | News
October 4, 2016, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), (“Veritas” or the “Company”) announces that it has received a quarterly research report from Cannevert Therapeutics Limited (CTL), lead researcher for Veritas. The...
